Report | CAMEO Chemicals

data unavailable

A solid complex between the cobalt(II) ion and the condensation product of salicylaldehyde and ethylenediamine. Such condensation products are called "Schiff's bases." Complexation with cobalt nullifies their basic properties. Used as a catalyst for various oxidation reactions in which it behaves as an oxygen carrier.

CAS Number	UN/NA Number	DOT Hazard Label	USCG CHRIS Code
14167-18-1	none	data unavailable	none
none	none

Known Catalytic Activity

No rapid reaction with air. No rapid reaction with water.

No information available.

SALCOMINE may increase the rate of oxidation reactions such as the conversion of amines to nitro compounds by peroxides or hydroperoxides.

Amines, Phosphines, and Pyridines
Salts, Acidic
Phenolic Salts

Use caution: Liquids with this reactive group classification have been known to react with the absorbent listed below.

Mineral-Based & Clay-Based Absorbents

No information available.

For emergency situations, wear a positive pressure, pressure-demand, full facepiece self-contained breathing apparatus (SCBA) or pressure- demand supplied air respirator with escape SCBA and a fully-encapsulating, chemical resistant suit. (EPA, 1998)

No information available.

Note: No information on specific clinical effects of exposure was available.

Signs and Symptoms of Salcomine Exposure: Signs and symptoms of acute exposure to salcomine may include headache, dizziness, weakness, and nausea. May cause irritation of the eyes, skin, and respiratory tract. Esophageal or gastrointestinal tract irritation or burns may also be noted.

Emergency Life-Support Procedures: Acute exposure to salcomine may require decontamination and life support for the victims. Emergency personnel should wear protective clothing appropriate to the type and degree of contamination. Air-purifying or supplied-air respiratory equipment should also be worn, as necessary. Rescue vehicles should carry supplies such as plastic sheeting and disposable plastic bags to assist in preventing spread of contamination.

Inhalation Exposure:
1. Move victims to fresh air. Emergency personnel should avoid self-exposure to salcomine.
2. Evaluate vital signs including pulse and respiratory rate, and note any trauma. If no pulse is detected, provide CPR. If not breathing, provide artificial respiration. If breathing is labored, administer 100% humidified oxygen or other respiratory support.
3. Obtain authorization and/or further instructions from the local hospital for performance of other invasive procedures.
4. Transport to a health care facility.

Dermal/Eye Exposure:
1. Remove victims from exposure. Emergency personnel should avoid self-exposure to salcomine.
2. Evaluate vital signs including pulse and respiratory rate, and note any trauma. If no pulse is detected, provide CPR. If not breathing, provide artificial respiration. If breathing is labored, administer 100% humidified oxygen or other respiratory support.
3. Remove contaminated clothing as soon as possible.
4. If eye exposure has occurred, eyes must be flushed with lukewarm water for at least 15 minutes.
5. Wash exposed skin areas thoroughly with soap and water.
6. Obtain authorization and/or further instructions from the local hospital for performance of other invasive procedures.
7. Transport to a health care facility.

Ingestion Exposure:
1. Evaluate vital signs including pulse and respiratory rate, and note any trauma. If no pulse is detected, provide CPR. If not breathing, provide artificial respiration. If breathing is labored, administer 100% humidified oxygen or other respiratory support.
2. Obtain authorization and/or further instructions from the local hospital for administration of an antidote or performance of other invasive procedures.
3. DO NOT induce vomiting.
4. Activated charcoal may be administered if victims are conscious and alert. Use 15 to 30 g (1/2 to 1 oz) for children, 50 to 100 g (1-3/4 to 3-1/2 oz) for adults, with 125 to 250 mL (1/2 to 1 cup) of water.
5. Promote excretion by administering a saline cathartic or sorbitol to conscious and alert victims. Children require 15 to 30 g (1/2 to 1 oz) of cathartic; 50 to 100 g (1-3/4 to 3-1/2 oz) is recommended for adults.
6. Transport to a health care facility. (EPA, 1998)

Chemical	PAC-1	PAC-2	PAC-3
Salcomine; (bis(Salicylaldehyde)ethylenediimine cobalt(II)) (14167-18-1)	3.5 mg/m3	39 mg/m3	230 mg/m3

Regulatory Name	CAS Number/ 313 Category Code	EPCRA 302 EHS TPQ	EPCRA 304 EHS RQ	CERCLA RQ	EPCRA 313 TRI	RCRA Code	CAA 112(r) RMP TQ
Salcomine	14167-18-1	500/10000 pounds	500 pounds

BIS(SALICYLALDEHYDE)ETHYLENEDIIMINE COBALT(II)
BIS(SALICYLIDENE)ETHYLENEDIAMINATOCOBALT(II)
[BIS(SALICYLIDENE)ETHYLENEDIAMINE]COBALT
COBALT BIS(SALICYLIDENE)ETHYLENEDIAMINE
COBALT, N,N'-ETHYLENEBIS(SALICYLIDENEIMINATO)-
COBALT, [[2,2'-[1,2-ETHANEDIYLBIS(NITRILOMETHYLIDYNE)]BIS[PHENOLATO]](2-)-N,N',O,O']-, (SP-4-2)-
COBALT, [[ALPHA,ALPHA'-(ETHYLENEDINITRILO)DI-O-CRESOLATO](2-)]-
COBALT,((2,2'-(1,2-ETHANEDIYLBIS(NITRILOMETHYLIDYNE))BIS(PHENOLATO))(2-)-N,N',O,O')-
COBALT,((ALPHA,ALPHA'-(ETHYLENEDINITRILO) DI-O-CRESOLATO)(2-))-
COSALEN
[N,N'-BIS(SALICYLIDENE)ETHYLENEDIAMINATO]COBALT
[N,N'-DISALICYLIDENEETHYLENEDIAMINE]COBALT
[N,N'-ETHYLENEBIS(SALICYLALDEHYDE IMINATO)]COBALT(II)
N,N'-ETHYLENEBIS(SALICYLIDENEIMINATO)COBALT(II)
N,N'-ETHYLENEBIS(SALICYLIDENIMINATO)COBALT(II)
[N,N'-ETHYLENEBIS(SALICYLIDENIMINATO)]COBALT
O-CRESOL, ALPHA,ALPHA'-(ETHYLENEDINITRILO)DI-, CO DERIV.
SALCOMIN
SALCOMINE
SALCOMINE POWDER

SALCOMINE

Chemical Identifiers

Hazards

Response Recommendations

Physical Properties

AEGLs (Acute Exposure Guideline Levels)

ERPGs (Emergency Response Planning Guidelines)

PACs (Protective Action Criteria)

Regulatory Information

EPA Consolidated List of Lists

CISA Chemical Facility Anti-Terrorism Standards (CFATS)

OSHA Process Safety Management (PSM) Standard List

Alternate Chemical Names